JFG
VRTX icon

Jefferies Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Jefferies Financial Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,400
Closed -$5.05M – 2064
2023
Q4 		$5.05M Buy
12,400
+3,400
+38% +$1.26M 0.03% 401
2023
Q3 		$3.13M Sell
9,000
-1,100
-11% -$385K 0.03% 475
2023
Q2 		$3.55M Buy
+10,100
New +$3.4M 0.03% 467
2023
Q1 		– Sell
-5,200
Closed -$1.5M – 2027
2022
Q4 		$1.5M Buy
+5,200
New +$1.58M 0.01% 755

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Jefferies Financial Group's VRTX Position: Q2 2026 in Review

Jefferies Financial Group reduced its Vertex Pharmaceuticals (VRTX) stake by 2.8% in Q2 2026, selling an estimated $291K and leaving 23,154 shares worth $11.5M. The position accounts for 0.08% of the portfolio, ranked #226.

Jefferies Financial Group first reported a position in VRTX in Q1 2016 and has held it in 16 quarters since. The position peaked at $28.3M in Q2 2024. 1,763 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Jefferies Financial Group held 23,154 shares of Vertex Pharmaceuticals worth $11.5M as of Q2 2026.
  • Jefferies Financial Group sold 656 Vertex Pharmaceuticals shares in Q2 2026, an estimated $291K.
  • Vertex Pharmaceuticals made up 0.08% of Jefferies Financial Group's portfolio in Q2 2026, its #226 holding.
  • Jefferies Financial Group first reported a position in Vertex Pharmaceuticals in Q1 2016 and has held it in 16 quarters since.
  • Jefferies Financial Group's Vertex Pharmaceuticals position peaked at $28.3M in Q2 2024.
  • 1,763 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.